{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:13:24Z","timestamp":1790727204604,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.abd.2021.09.010","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T07:29:26Z","timestamp":1654932566000},"page":"409-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Epidermolysis bullosa acquisita"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4475","authenticated-orcid":false,"given":"Denise","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-5808","authenticated-orcid":false,"given":"Juliana Olivieri","family":"Gordilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-4254","authenticated-orcid":false,"given":"Claudia Giuli","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4790","authenticated-orcid":false,"given":"Adriana Maria","family":"Porro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","article-title":"Epidermolysis bullosa acquisita. Report of three cases and review of all published cases","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archderm.1965.01600090027004","article-title":"Epidermolysis bullosa acquisita: a disease of dermal connective tissue","volume":"91","author":"Pass","year":"1965","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0015","first-page":"1143","article-title":"The immunopathology of epidermolysis bullosa acquisita","volume":"108","author":"Kushniruk","year":"1973","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.abd.2021.09.010_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1523-1747.ep12526124","article-title":"Epidermolysis bullosa acquisita: ultrastructural and immunological studies","volume":"76","author":"Yaoita","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1980.tb06550.x","article-title":"Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients","volume":"102","author":"Nieboer","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0738-081X(00)00186-3","article-title":"Epidermolysis bullosa acquisita: update and review","volume":"19","author":"Hallel-Halevy","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.abd.2021.09.010_bib0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.autrev.2019.06.007","article-title":"Epidermolysis bullosa acquisita: A comprehensive review","volume":"18","author":"Kridin","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.abd.2021.09.010_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.1995.01690200097021","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archderm.1990.01670260041007","article-title":"Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies","volume":"126","author":"Zhu","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clindermatol.2011.03.011","article-title":"Epidermolysis bullosa acquisita","volume":"30","author":"Gupta","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.abd.2021.09.010_bib0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40272-019-00349-3","article-title":"Bullous diseases in children: a review of clinical features and treatment options","volume":"21","author":"Schultz","year":"2019","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.abd.2021.09.010_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archdermatol.2010.317","article-title":"Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant","volume":"147","author":"Abrams","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0080","article-title":"Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita","volume":"2013","author":"Ludwig","year":"2013","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2015.08.007","article-title":"Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita","volume":"68","author":"Ellebrecht","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.abd.2021.09.010_bib0090","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3462","article-title":"Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering","volume":"4","author":"Srinivas","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.abd.2021.09.010_bib0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0100","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1586\/1744666X.2015.1085801","article-title":"Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita","volume":"11","author":"Ludwig","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.010_bib0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.det.2011.03.003","article-title":"Pathogenesis of epidermolysis bullosa acquisita","volume":"29","author":"Ludwig","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2021.09.010_bib0110","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/jdv.12096","article-title":"Epidermolysis bullosa acquisita","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2012.08.002","article-title":"Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction","volume":"40","author":"Samavedam","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.abd.2021.09.010_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916934.2011.606450","article-title":"Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen","volume":"45","author":"Chen","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.abd.2021.09.010_bib0125","doi-asserted-by":"crossref","first-page":"21649","DOI":"10.1074\/jbc.M100180200","article-title":"The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.abd.2021.09.010_bib0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/00015555-1065","article-title":"Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0190-9622(84)80459-4","article-title":"Epidermolysis bullosa acquisita \u2012 a pemphigoid-like disease","volume":"11","author":"Gammon","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0145","first-page":"111","article-title":"Review and update of epidermolysis bullosa acquisita","volume":"7","author":"Woodley","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archderm.135.8.954","article-title":"Mucosal morbidity in patients with epidermolysis bullosa acquisita","volume":"135","author":"Luke","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0155","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/bjd.13144","article-title":"Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain","volume":"171","author":"Iranzo","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0160","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjd.13224","article-title":"Oesophageal involvement in epidermolysis bullosa acquisita","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0190-9622(97)80408-2","article-title":"Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits","volume":"36","author":"Taniuchi","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1684\/ejd.2010.1002","article-title":"Severe acral contractures and nail loss in a patient with mechano-bullous Epidermolysis bullosa acquisita","volume":"20","author":"Meissner","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2230.2008.02875.x","article-title":"Epidermolysis bullosa acquisita requiring multiple oesophageal dilatations","volume":"33","author":"Shipman","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.md.0000231954.08350.52","article-title":"A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid","volume":"85","author":"Alexandre","year":"2006","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.abd.2021.09.010_bib0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1067\/mjd.2002.125079","article-title":"IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature","volume":"47","author":"Vodegel","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.1991.01680030111016","article-title":"Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid","volume":"127","author":"Kurzhals","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0195","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jaad.2008.12.020","article-title":"A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine","volume":"61","author":"Tanaka","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamadermatol.2013.4972","article-title":"Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire","volume":"149","author":"Sebaratnam","year":"2013","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.abd.2021.09.010_bib0205","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bjd.12623","article-title":"The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease","volume":"169","author":"Tjokrowidjaja","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0210","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","article-title":"The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn\u2019s disease have autoantibodies to type VII collagen","volume":"118","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ced.12114","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature","volume":"38","author":"Reddy","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0220","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.det.2011.03.017","article-title":"Diagnosis and clinical features of epidermolysis bullosa acquisita","volume":"29","author":"Caux","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2021.09.010_bib0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1590\/abd1806-4841.20143221","article-title":"Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience","volume":"89","author":"Arbache","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.010_bib0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.annder.2011.01.013","article-title":"Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de reference des maladies bulleuses auto-immunes. Societe Francaise de Dermatologie","volume":"138","author":"Prost-Squarcioni","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.abd.2021.09.010_bib0245","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.jaad.2013.01.025","article-title":"IgG autoantibody subclass analysis as a tool to differentiate epidermolysis bullosa acquisita with overlapping features of bullous systemic lupus erythematosus","volume":"69","author":"Gual","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0250","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0255","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1067\/mjd.2003.99","article-title":"Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy","volume":"48","author":"Vodegel","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0260","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/ijd.13580","article-title":"Porphyria cutanea tarda: an intriguing genetic disease and marker","volume":"56","author":"Handler","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0265","first-page":"26","article-title":"Direct immunofluorescence of mechanobullous epidermolysis bullosa acquisita, porphyria cutanea tarda and pseudoporphyria","volume":"99","author":"de Groot","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jdv.12129","article-title":"Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients","volume":"28","author":"Calabresi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0275","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/jdv.15679","article-title":"Review of autoimmune blistering diseases: the Pemphigoid diseases","volume":"33","author":"Daniel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.010_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The diagnosis and blistering mechanisms of mucous membrane pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.09.010_bib0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40257-014-0098-0","article-title":"Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment","volume":"15","author":"Contestable","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.det.2018.12.003","article-title":"Treatment update of autoimmune blistering diseases","volume":"37","author":"Kridin","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2021.09.010_bib0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/abd1806-4841.2019940207","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita \u2012 Brazilian Society of Dermatology","volume":"94","author":"Santi","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0300","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40257-020-00513-3","article-title":"A review comparing international guidelines for the management of bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, and epidermolysis bullosa acquisita","volume":"21","author":"Patel","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0305","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0310","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/14656566.2011.549127","article-title":"Current concepts in the treatment of epidermolysis bullosa acquisita","volume":"12","author":"Gurcan","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.abd.2021.09.010_bib0315","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2012.04.008","article-title":"Corticosteroid use in autoimmune blistering diseases","volume":"32","author":"Frew","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.abd.2021.09.010_bib0320","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/jid.2013.91","article-title":"Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation","volume":"133","author":"Hellberg","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0325","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1346-8138.13395","article-title":"Oral colchicine monotherapy for epidermolysis bullosa acquisita: Mechanism of action and efficacy","volume":"43","author":"Adachi","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0330","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jdcr.2015.07.007","article-title":"Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up","volume":"1","author":"Sami","year":"2015","journal-title":"JAAD case reports"},{"key":"10.1016\/j.abd.2021.09.010_bib0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","article-title":"Immunosuppressive therapy for autoimmune bullous diseases","volume":"30","author":"Meurer","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318600-000000000-00000","article-title":"Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management","volume":"27","author":"Mutasim","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.abd.2021.09.010_bib0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/09546634.2016.1179711","article-title":"Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy","volume":"28","author":"Oktem","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2021.09.010_bib0350","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12726","article-title":"The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature","volume":"31","author":"Bevans","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2021.09.010_bib0355","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08916934.2011.606452","article-title":"Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update","volume":"45","author":"Czernik","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.abd.2021.09.010_bib0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000478078","article-title":"Bullous Diseases","volume":"53","author":"Corbaux","year":"2018","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0365","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ajd.12795","article-title":"Colchicine in dermatology: A review","volume":"59","author":"Robinson","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0370","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0375","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/eci.11.22","article-title":"Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses","volume":"7","author":"Feldman","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.010_bib0380","series-title":"Intravenous Immunoglobulin Therapy","first-page":"397","author":"Sulk","year":"2021"},{"key":"10.1016\/j.abd.2021.09.010_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.2010.03845.x","article-title":"Clinical and immunopathological evaluation of epidermolysis bullosa acquisita","volume":"36","author":"Delgado","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0390","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/0019-5154.182420","article-title":"Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting","volume":"61","author":"Goyal","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0395","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjd.12011","article-title":"Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study","volume":"168","author":"Marzano","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.010_bib0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:57Z","timestamp":1759794057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0365059622000885"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.010","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermolysis bullosa acquisita","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}